当前位置:首页 - 行情中心 - 安科生物(300009) - 财务分析

安科生物

(300009)

  

流通市值:119.75亿  总市值:165.17亿
流通股本:12.16亿   总股本:16.77亿

安科生物(300009)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润2.22亿元,每股收益0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益416589.52万元,未分配利润161551.96万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产512670.56万元,负债96081.04万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入656,092,096.172,865,752,059.952,021,384,056.691,287,279,354.46
营业总成本412,632,143.811,930,498,177.721,257,752,219.43826,263,354.01
营业利润257,600,663.55923,979,111.22768,473,455.84463,615,476.94
利润总额257,619,264.62919,929,605.88767,775,513.1463,508,351.45
净利润221,942,342.95858,588,991.57664,620,477.53401,863,500.55
其他综合收益----
综合收益总额221,942,342.95858,588,991.57664,620,477.53401,863,500.55
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,512,247,494.212,325,483,458.752,090,507,909.851,854,095,806.78
非流动资产合计2,614,458,147.182,625,277,027.292,500,725,411.972,398,468,881.22
资产总计5,126,705,641.394,950,760,486.044,591,233,321.824,252,564,688
流动负债合计793,045,617.92847,080,888.86685,340,135.13645,144,834.82
非流动负债合计167,764,792.3171,347,690.88182,192,046.29178,373,891.43
负债合计960,810,410.221,018,428,579.74867,532,181.42823,518,726.25
归属于母公司股东权益合计3,966,402,036.483,737,399,547.013,522,940,262.13,240,264,828.5
股东权益合计4,165,895,231.173,932,331,906.33,723,701,140.43,429,045,961.75
负债和股东权益合计5,126,705,641.394,950,760,486.044,591,233,321.824,252,564,688
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计623,525,658.512,567,892,245.451,903,924,209.881,183,476,049.11
经营活动现金流出小计468,795,288.461,614,921,345.871,278,094,655.22850,576,488.68
经营活动产生的现金流量净额154,730,370.05952,970,899.58625,829,554.66332,899,560.43
投资活动现金流入小计905,331,713.15872,931,734.08738,950,870.26763,110,310.54
投资活动现金流出小计1,002,074,899.51,490,203,341.361,038,727,693.18752,710,744.94
投资活动产生的现金流量净额-96,743,186.35-617,271,607.28-299,776,822.9210,399,565.6
筹资活动现金流入小计-41,057,57622,010,00010,000,000
筹资活动现金流出小计2,197,333.4442,051,672.55427,815,654.59423,950,254.89
筹资活动产生的现金流量净额-2,197,333.4-400,994,096.55-405,805,654.59-413,950,254.89
汇率变动对现金及现金等价物的影响13,564.21-107,327.13-310,829.81-79,474.37
现金及现金等价物净增加额55,803,414.51-65,402,131.38-80,063,752.66-70,730,603.23
期末现金及现金等价物余额314,587,364.25258,783,949.74244,122,328.46253,455,477.89
最新报告期:2024-04-09
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
华鑫证券吴景欢,胡博新0.640.811.012024-04-09
国金证券袁维0.640.811.012024-03-27
广发证券罗佳荣0.680.85--2024-03-12
国金证券袁维0.670.83--2024-03-09
西南证券杜向阳0.620.77--2024-03-07
TOP↑